Two
new editions of the Pharmacpeial Forum has recently been issued (Vol. 39, No.4
and Vol. 39 No.5). Amongst the items of interest are:
Chapter111 Design and Analysis of Biological Assays (Revision
proposal target, USP37-NF32 2S)
USP
has developed four general information chapters pertinent to bioassays: 1030, 1032, 1033, and 1034. The latter three
became official August 1, 2012, and 1030 will become official December 1, 2013.
These new chapters largely replace the current general chapter 111. It is now proposed
to replace the current 111 with a completely revised 111 that covers a much
reduced set of topics appropriate for a chapter numbered below 1000.
Chapter
1240 Virus Testing of Human Plasma for
Further Manufacture
(Revision
proposal target, USP37-NF32 2S)
Human-plasma-derived
products are manufactured from donated human plasma and include many
therapeutically important medicines. The scope of this new general information
chapter is virus testing performed on human plasma for further manufacture of
pharmaceuticals. The chapter also contains an Appendix with regulatory
guidances and references that support the recommendations.
Chapter
791 pH (Revision proposal target,
USP37-NF32 2S)
Posted by Tim Sandle
No comments:
Post a Comment
Pharmaceutical Microbiology Resources